Mergers & Acquisitions


Current filters:


Popular Filters

770 to 794 of 922 results

Gen-Probe agrees $3.7 billion acquisition by Hologic


USA-based Hologic (Nasdaq: HOLX) said it has reached an agreement to acquire Gen-Probe (Nasdaq: ASDAQ)…

Gen-ProbeHologicMergers & AcquisitionsPharmaceutical

Haemonetics to buy Pall Corp blood collection and processing lines for $550 million; and Hemerus Medical


USA-based Pall Corp (NYSE: PLL) has entered into an agreement to sell certain assets of its blood collection,…

HaemoneticsHemerus MedicalMergers & AcquisitionsPall CorpPharmaceutical

Jazz Pharma to acquire EUSA Pharma for up to $700 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) said last week that it has signed a definitive accord…

EUSA PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceutical

Global generic drug markets will grow to $221 billion by 2016; Espicom


The economic recession has been a double-edged sword for the international generic drugs business. Driven…

GenericsGlobalMarkets & MarketingMergers & AcquisitionsPricing

Amylin operating loss leaps to over $30 million


US biotech firm Amylin Pharmaceuticals (Nasdaq AMLN): reported financial results for the quarter ended…

AmylinBiotechnologyFinancialMergers & Acquisitions

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis


US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Watson Pharma confirms buy of generic group Actavis for 4.25 billion euros


As has been widely rumoured over this week, Watson Pharmaceuticals (NYSE: WPI) has confirmed a definitive…

ActavisGenericsMergers & AcquisitionsWatson Pharmaceuticals

Amgen acquires Turkish drugmaker Mustafa Nevzat for $700 million


Global biotech giant Amgen (Nasdaq: AMGN) has reached agreement to acquire 95.6% of Mustafa Nevzat Pharmaceuticals…

AmgenBiotechnologyMergers & AcquisitionsMustafa Nevzat PharmaPharmaceutical

Biota and Nabi announce proposed merger


Australian firm Biota Holdings (ASX: BTA) and USA-based Nabi Biopharmaceuticals (Nasdaq: NABI) yesterday…

Biota HoldingsBiota PharmaceuticalsBiotechnologyMergers & AcquisitionsNabi BiopharmaceuticalsPharmaceutical

Pfizer sells Nutrition business to Nestle for $11.85 billion


Swiss food giant Nestle has won the battle to acquire the Nutrition business of global drugs behemoth…

Mergers & AcquisitionsNestlePfizerPharmaceutical

EU Commission OKs J&J's buy of Synthes, but with conditions


The European Commission last week cleared under the EU Merger Regulation the proposed $21.3 billion acquisition…

Johnson & JohnsonMergers & AcquisitionsPharmaceuticalSynthes

Human Genome rejects unsolicited takeover bid from GlaxoSmithKline


US drugmaker Human Genome Sciences (Nasdaq: HGSI) revealed yesterday that it has rejected an unsolicited…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Roche will not extend its tender offer for Illumina


In view of the apparent re-election of the incumbent directors of Illumina (Nasdaq: ILMN), a leading…

BiotechnologyIlluminaMergers & AcquisitionsPharmaceuticalRoche

Piramal buys molecular imaging portfolio from Bayer


Indian drugmaker Piramal Healthcare (BSE: 500302) says it has signed an agreement to acquire worldwide…

BayerflorbetabenMergers & AcquisitionsPharmaceuticalPiramal Healthcare

Roche ratchets up the pressure on Illumina; analytical view


If there is an axiom to describe Swiss drug major Roche (ROG: SIX), it is that what Roche wants, it gets,…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Shire inks deal to buy Pervasis, adding Ph II drug candidate


Ireland-headquartered biopharma firm Shire (LSE: SHP) said yesterday that it has signed an agreement…

Mergers & AcquisitionsPervasis TherapeuticsPharmaceuticalShire

Valeant Pharma to acquire podiatry firm Pedinol


In a fourth takeover deal so far this year, Canadian drugmaker Valeant Pharmaceuticals International.…

Mergers & AcquisitionsPedinol PharmacalPharmaceuticalValeant Pharmaceuticals

Takeda to acquire URL Pharma for $800 million


Japanese drug major Takeda Pharmaceutical (TYO: 4502) said yesterday that it has reached agreement to…

ColcrysMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsUloricURL Pharma

Arrowhead takes over Alvos Thera in stock deal


USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) says it has acquired Alvos Therapeutics…

Alvos TherapeuticsArrowhead ResearchBiotechnologyMergers & AcquisitionsPharmaceutical

Amgen to snap up KAI Pharma for $315 million


In a second acquisition announced so far this year, global biotech leader Amgen (Nasdaq: AMGN) said yesterday…

AmgenBiotechnologyKAI PharmaceuticalsMergers & AcquisitionsNephrology and Hepatology

770 to 794 of 922 results

Back to top